MENU
ANIP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ANI Pharmaceuticals (ANIP) Ownership - Who owns ANI Pharmaceuticals?

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals... Show more

Profile

Industry
Pharmaceuticals Other
Address
210 Main Street West
Phone
+1 218 634-3500
Employees
642
Web
https://www.anipharmaceuticals.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.85B
P/E Ratio
51.36
Total Cash
271.47M
Projected Growth
N/A
Total Debt
620.31M
Revenue
826.88M
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash/Share
12.09
Total Debt/Equity
N/A
Revenue/Share
40.25 USD as % of share price

Fundamentals

ANIP
Capitalization
1.85B
P/E Ratio
51.36
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash
271M
Total Cash/Share
12.09
Total Debt
620M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
40.25%
Revenue
827M
ROE
N/A
Book Value
506M
P/B Ratio
3.65
Cash Flow
N/A
Earnings
1.71
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
2.58
Current Revenue Per Employee
253972.12
Dividends Per Share - Security
N/A
EBITDA
164M
Float
N/A
Float - Current
N/A
Gross Income Margin
59.01
Revenue To Assets
2.89
Shares Held By Institutions
2.53B
Shares Outstanding - Current
22.5M
Total Liabilities
902M
Total Volume MTD
N/A
Value
-1
Gain YTD
48.661
View a ticker or compare two or three
ANIP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANIP showed earnings on November 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of branded and generic prescription pharmaceuticals

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
210 Main Street West
Phone
+1 218 634-3500
Employees
642
Web
https://www.anipharmaceuticals.com